Estimate Recalculated Nov 11, 2024 01:51PM EST
Matthew R Patterson has an estimated net worth of $23.8 Million. This is based on reported shares across multiple companies, which include Vor Biopharma Inc., AMICUS THERAPEUTICS INC, 5:01 Acquisition Corp., Homology Medicines, Inc., and Audentes Therapeutics, Inc..
Matthew R Patterson's CIK is 0001401018
2018 was Matthew R Patterson's most active year for acquiring shares with 15 total transactions. Matthew R Patterson's most active month to acquire stocks was the month of January. 2008 was Matthew R Patterson's most active year for disposing of shares, totalling 100 transactions. Matthew R Patterson's most active month to dispose stocks was the month of May. 2019 saw Matthew R Patterson paying a total of $349,067.00 for 312,156 shares, this is the most they've acquired in one year. In 2020 Matthew R Patterson cashed out on 1,158,349 shares for a total of $15,687,480.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!